GRRMF

Gerresheimer AG

GRRMF, USA

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

https://www.gerresheimer.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
GRRMF
stock
GRRMF

Bernstein Maintains GERRESHEIMER AG(GRRMF.US) With Sell Rating, Cuts Target Price to $29.89 富途资讯

Read more →
GRRMF
stock
GRRMF

Bernstein Initiates GERRESHEIMER AG(GRRMF.US) With Sell Rating, Announces Target Price $30.15 富途资讯

Read more →

Showing 2 of 4

Finn Analysis

(Last Updated 2025-05-31)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

65.08

Low 50

High 10

Price to Book Ratio (P/B)

-

Very Low

1.23

Low 1

High 3

Return on Equity (ROE)

-

Very Low

1.18 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

0.36 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Medium

10.33 %

Low 5%

High 15%

Debt to Equity

-

Very Low

2.28

Low 1

High 0.3

Investors

* Institutions hold a combined 0.00% of the total shares of Gerresheimer AG

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-11-30

EPS Estimate

1.15

Latest Release

Date

2025-08-31

EPS Actual

-0.4272

EPS Estimate

0.83

EPS Difference

-1.2572

Surprise Percent

-151.4699%

Investing Fit Scorecard

(Last Updated 2025-05-31)

Deep Value
Potential Value Candidate(5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Fair GARP(3.5)
Growth
Moderate Growth(3.5)
Momentum
Moderate Momentum(5)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(4)
Value
Fair Value(6)

Income Statement

(Last Updated 2025-05-31)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-05-31)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-05-31)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.